サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1134949

更年期ホットフラッシュの世界市場規模調査＆予測、治療タイプ別（ホルモン治療、非ホルモン治療）、地域別分析、2022-2029年

Global Menopausal Hot Flashes Market Size study & Forecast, by Treatment Type (Hormonal Treatment and Non-hormonal Treatment) and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
更年期ホットフラッシュの世界市場規模調査＆予測、治療タイプ別（ホルモン治療、非ホルモン治療）、地域別分析、2022-2029年
出版日: 2022年10月08日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

更年期のホットフラッシュは、女性の更年期障害に伴うエストロゲン濃度の低下によってもたらされる複雑なホルモンの調整によって引き起こされることが多いのです。

体温調節機能が低下するため、体が温かく感じられるようになります。平均して7年以上、ひどい場合は10年以上続くこともある病気です。正常な状態であるが、飲酒、熱いものを食べる、喫煙、ストレスを受ける、などの要因によって引き起こされることがあります。更年期障害とその治療に関する意識の高まりや、栄養補助食品の利点を裏付ける研究の増加といった主要因が、市場の成長を牽引しています。

Kimberly Peacockらによる「Menopause（Nursing）」2022年2月号によると、米国では毎年約130万人の女性が51～52歳の間に月経を停止しており、40～45歳の女性の約5％が早期閉経を迎えると言われています。また、ほてりの治療法開発を目的とした研究が重視されるようになり、市場が拡大しています。例えば、2021年12月に誘導性血管運動症状の治療の可能性を示す選択的非ペプチド性ニューロキニン3受容体（NK3R）拮抗薬、ACER-801（osanetant）の治験薬（IND）申請について、エイサーセラピューティクス社（FDA）の承認を取得しました。（iVMS）を開発しました。しかし、ホルモン製剤に関連する副作用は、2022年から2029年の予測期間を通じて市場の成長を阻害します。

世界の更年期ホットフラッシュ市場調査のために考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域が含まれます。北米は、更年期障害の発生率が高く、高齢の女性の割合が多いことから、市場全体のシェアをリードしています。しかし、アジア太平洋地域は、医療観光の増加や人々の意識の高まりにより、最も急速に成長する地域と予想されます。

本レポートに含まれる主な市場参入企業は以下の通りです。

  • Bristol-Myers Squibb Company
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Hisamitsu Pharmaceutical Co. Inc.
  • AstraZeneca PLC
  • Agile Therapeutics
  • Novo Nordisk Corporation
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Ferring BV

本調査の目的は、近年における様々なセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的および量的側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します。

治療タイプ別

非ホルモン治療

ホルモン治療

地域別

北米

米国

カナダ

欧州

英国

ドイツ

フランス

スペイン

イタリア

その他欧州

アジア太平洋地域

中国

インド

日本

オーストラリア

韓国

その他アジア太平洋

ラテンアメリカ

ブラジル

メキシコ

世界のその他の地域

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 更年期ホットフラッシュ市場：地域別、2019-2029年
    • 更年期ホットフラッシュ市場：治療タイプ別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 更年期ホットフラッシュの世界市場：定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 更年期ホットフラッシュの世界市場の力学

  • 更年期ホットフラッシュの市場インパクト分析（2019-2029年）
    • 市場促進要因
      • 更年期障害とその治療に関する認知度の向上
      • 栄養補助食品の利点を支持する研究の増加
    • 市場の課題
      • ジェネリック医薬品の利用可能性
      • ホルモン剤に関連する副作用
    • 市場機会
      • 先進的な製品の開発

第4章 世界の更年期ホットフラッシュ市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 更年期ホットフラッシュの世界市場：治療タイプ別

  • 市場スナップショット
  • 更年期ほてりの世界市場：治療タイプ別パフォーマンス-ポテンシャル分析
  • 更年期ほてりの世界市場、治療タイプ別推定・予測2019～2029年
  • 更年期ホットフラッシュ市場、サブセグメント分析
    • 非ホルモン治療
    • ホルモン治療

第7章：更年期ホットフラッシュの世界市場：地域別分析

  • 更年期ホットフラッシュ症の世界市場：地域別市場スナップショット
  • 北米
    • 米国
      • 治療タイプ別の推定・予測、2019年～2029年
    • カナダ
  • 欧州更年期ほてり市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域の更年期ほてり市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの更年期障害別ほてり市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Bristol-Myers Squibb Company
      • 主な情報
      • 概要
      • 財務（データの入手状況により異なります）
      • 製品概要
      • 最近の開発状況
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd
    • Hisamitsu Pharmaceutical Co. Inc.
    • AstraZeneca PLC
    • Agile Therapeutics
    • Novo Nordisk Corporation
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Ferring BV

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Menopausal Hot Flashes Market, report scope
  • TABLE 2. Global Menopausal Hot Flashes Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Menopausal Hot Flashes Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
  • TABLE 4. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Menopausal Hot Flashes Market
  • TABLE 69. List of primary sources, used in the study of global Menopausal Hot Flashes Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Menopausal Hot Flashes Market, research methodology
  • FIG 2. Global Menopausal Hot Flashes Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Menopausal Hot Flashes Market, key trends 2021
  • FIG 5. Global Menopausal Hot Flashes Market, growth prospects 2022-2029
  • FIG 6. Global Menopausal Hot Flashes Market, porters 5 force model
  • FIG 7. Global Menopausal Hot Flashes Market, pest analysis
  • FIG 8. Global Menopausal Hot Flashes Market, value chain analysis
  • FIG 9. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Menopausal Hot Flashes Market, regional snapshot 2019 & 2029
  • FIG 15. North America Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Menopausal Hot Flashes Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Menopausal Hot Flashes Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.4% over the forecast period 2022-2029. Menopausal hot flashes are often brought on by the intricate hormonal adjustments brought on by the lowering oestrogen levels as menopause occurs in women. The body feels warm because of declining levels' effects on thermoregulation. On average, the illness can persist over 7 years, and in the most severe cases, it can last up to 10 years. Although it is a normal condition, it can be brought on by factors like drinking alcohol, eating hot food, smoking, being stressed, and other things. The market growth is driven by key factors such as increasing awareness about menopause and its treatment and increasing research supporting advantages of dietary supplements.

In the United States, roughly 1.3 million women cease menstruation each year, beginning between the ages of 51 and 52, according to the February 2022 version of "Menopause (Nursing)" by Kimberly Peacock et al. About 5% of women between the ages of 40 and 45 undergo early menopause, according to the same source. The market is also expanding as a result of the growing emphasis on research aimed at the development of treatments for hot flashes. For instance, Acer Therapeutics Inc. received FDA approval for its investigational new drug (IND) application for its selective non-peptide neurokinin 3 receptors (NK3R) antagonist, ACER-801 (osanetant), for the possible treatment of induced Vasomotor Symptoms in December 2021. (iVMS). However, side Effects Associated with Hormonal Products stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Menopausal Hot Flashes Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to increased incidence of menopause and presence of a large percentage of older women in the region. However, Asia Pacific is expected to be the fastest growing region due to increased medical tourism and growing public awareness in the region.

Major market players included in this report are:

Bristol-Myers Squibb Company

Novartis AG

Teva Pharmaceutical Industries Ltd

Hisamitsu Pharmaceutical Co. Inc.

AstraZeneca PLC

Agile Therapeutics

Novo Nordisk Corporation

Pfizer Inc.

Merck & Co. Inc.

Ferring BV

Recent Developments in the Market:

  • The U.S. Food and Drug Administration received a new drug application (NDA) for fezolinetant from Astellas Pharma Inc. in June 2022. (FDA). For the treatment of mild to severe vasomotor symptoms (VMS) related to menopause, the experimental oral, nonhormonal chemical fezolinetant is appealing for approval.
  • In order to increase the number of drugs in its pipeline, Bayer, a leading global supplier of healthcare for women, purchased KaNDy Therapeutics Ltd. in August 2020. For the treatment of menopausal symptoms, KaNDy Therapeutics Ltd. has finished the Phase IIb trials of NT-814, a first-in-class, non-hormonal neurokinin-1,3 receptor antagonist.

Global Menopausal Hot Flashes Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Treatment Type, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Non-hormonal Treatment

Hormonal Treatment

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Menopausal Hot Flashes Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Menopausal Hot Flashes Market, by Treatment Type, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Menopausal Hot Flashes Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Menopausal Hot Flashes Market Dynamics

  • 3.1. Menopausal Hot Flashes Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing awareness about menopause and its treatment
      • 3.1.1.2. Increasing research supporting advantages of dietary supplements
    • 3.1.2. Market Challenges
      • 3.1.2.1. Availability of Generic Medicines
      • 3.1.2.2. Side Effects Associated with Hormonal Products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Development of advanced products

Chapter 4. Global Menopausal Hot Flashes Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Menopausal Hot Flashes Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Menopausal Hot Flashes Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Menopausal Hot Flashes Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
  • 6.4. Menopausal Hot Flashes Market, Sub Segment Analysis
    • 6.4.1. Non-hormonal Treatment
    • 6.4.2. Hormonal Treatment

Chapter 7. Global Menopausal Hot Flashes Market, Regional Analysis

  • 7.1. Menopausal Hot Flashes Market, Regional Market Snapshot
  • 7.2. North America Menopausal Hot Flashes Market
    • 7.2.1. U.S. Menopausal Hot Flashes Market
      • 7.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Menopausal Hot Flashes Market
  • 7.3. Europe Menopausal Hot Flashes Market Snapshot
    • 7.3.1. U.K. Menopausal Hot Flashes Market
    • 7.3.2. Germany Menopausal Hot Flashes Market
    • 7.3.3. France Menopausal Hot Flashes Market
    • 7.3.4. Spain Menopausal Hot Flashes Market
    • 7.3.5. Italy Menopausal Hot Flashes Market
    • 7.3.6. Rest of Europe Menopausal Hot Flashes Market
  • 7.4. Asia-Pacific Menopausal Hot Flashes Market Snapshot
    • 7.4.1. China Menopausal Hot Flashes Market
    • 7.4.2. India Menopausal Hot Flashes Market
    • 7.4.3. Japan Menopausal Hot Flashes Market
    • 7.4.4. Australia Menopausal Hot Flashes Market
    • 7.4.5. South Korea Menopausal Hot Flashes Market
    • 7.4.6. Rest of Asia Pacific Menopausal Hot Flashes Market
  • 7.5. Latin America Menopausal Hot Flashes Market Snapshot
    • 7.5.1. Brazil Menopausal Hot Flashes Market
    • 7.5.2. Mexico Menopausal Hot Flashes Market
  • 7.6. Rest of The World Menopausal Hot Flashes Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Bristol-Myers Squibb Company
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Novartis AG
    • 8.2.3. Teva Pharmaceutical Industries Ltd
    • 8.2.4. Hisamitsu Pharmaceutical Co. Inc.
    • 8.2.5. AstraZeneca PLC
    • 8.2.6. Agile Therapeutics
    • 8.2.7. Novo Nordisk Corporation
    • 8.2.8. Pfizer Inc.
    • 8.2.9. Merck & Co. Inc.
    • 8.2.10. Ferring BV

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption